Design of Wide-Spectrum Inhibitors Targeting Coronavirus Main Proteases.
Yang, H., Xie, W., Xue, X., Yang, K., Ma, J., Liang, W., Zhao, Q., Zhou, Z., Pei, D., Ziebuhr, J., Hilgenfeld, R., Yuen, K.Y., Wong, L., Gao, G., Chen, S., Chen, Z., Ma, D., Bartlam, M., Rao, Z.(2005) PLoS Biol 3: 324-334
- PubMed: 16128623 
- DOI: 10.1371/journal.pbio.0030324
- Primary Citation of Related Structures:  
1WOF, 2AMQ, 2AMP, 2AMD, 2D2D - PubMed Abstract: 
The genus Coronavirus contains about 25 species of coronaviruses (CoVs), which are important pathogens causing highly prevalent diseases and often severe or fatal in humans and animals. No licensed specific drugs are available to prevent their infection. Different host receptors for cellular entry, poorly conserved structural proteins (antigens), and the high mutation and recombination rates of CoVs pose a significant problem in the development of wide-spectrum anti-CoV drugs and vaccines ...